122 related articles for article (PubMed ID: 7142342)
1. Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography.
Küpfer A; James R; Carr K; Branch R
J Chromatogr; 1982 Oct; 232(1):93-100. PubMed ID: 7142342
[TBL] [Abstract][Full Text] [Related]
2. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.
Meier UT; Kronbach T; Meyer UA
Anal Biochem; 1985 Dec; 151(2):286-91. PubMed ID: 4096368
[TBL] [Abstract][Full Text] [Related]
3. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
Küpfer A; Lawson J; Branch RA
Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
[TBL] [Abstract][Full Text] [Related]
4. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
Küpfer A; Brilis GM; Watson JT; Harris TM
Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
[TBL] [Abstract][Full Text] [Related]
5. Mephenytoin hydroxylation deficiency: kinetics after repeated doses.
Küpfer A; Desmond P; Patwardhan R; Schenker S; Branch RA
Clin Pharmacol Ther; 1984 Jan; 35(1):33-9. PubMed ID: 6690169
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
Küpfer A; Preisig R
Eur J Clin Pharmacol; 1984; 26(6):753-9. PubMed ID: 6489416
[TBL] [Abstract][Full Text] [Related]
7. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
Maguire JH; Kraus BL; Butler TC; Dudley KH
Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
[TBL] [Abstract][Full Text] [Related]
8. Stereoselectivity of differential routes of drug metabolism: the fate of the enantiomers of [14C]mephenytoin in the dog.
Küpfer A; Bircher J
J Pharmacol Exp Ther; 1979 May; 209(2):190-5. PubMed ID: 438994
[No Abstract] [Full Text] [Related]
9. Characterization of mephenytoin metabolites in human urine by gas chromatography and mass spectrometry.
Lynn RK; Bauer JE; Gordon WP; Smith RG; Griffin D; Thompson RM; Jenkins R; Gerber N
Drug Metab Dispos; 1979; 7(3):138-44. PubMed ID: 38083
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
Küpfer A; Branch RA
Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man.
Wedlund PJ; Sweetman BJ; Wilkinson GR; Branch RA
Drug Metab Dispos; 1987; 15(2):277-9. PubMed ID: 2882992
[No Abstract] [Full Text] [Related]
12. Evidence for the epoxide-diol pathway in the biotransformation of mephenytoin.
Gerber N; Thompson RM; Smith RG; Lynn RK
Epilepsia; 1979 Jun; 20(3):287-94. PubMed ID: 446437
[TBL] [Abstract][Full Text] [Related]
13. Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.
Wedlund PJ; Sweetman BJ; McAllister CB; Branch RA; Wilkinson GR
J Chromatogr; 1984 Apr; 307(1):121-7. PubMed ID: 6725478
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
Küpfer A; Patwardhan R; Ward S; Schenker S; Preisig R; Branch RA
J Pharmacol Exp Ther; 1984 Jul; 230(1):28-33. PubMed ID: 6747829
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective metabolism of mephenytoin in man.
Küpfer A; Roberts RK; Schenker S; Branch RA
J Pharmacol Exp Ther; 1981 Jul; 218(1):193-9. PubMed ID: 7241378
[No Abstract] [Full Text] [Related]
16. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
Maguire JH; Butler TC; Dudley KH
Drug Metab Dispos; 1982; 10(6):595-8. PubMed ID: 6130906
[TBL] [Abstract][Full Text] [Related]
17. Identification of mephenytoin metabolites in the dog.
Karlaganis G; Küpfer A; Bircher J; Schlunegger UP; Gfeller H; Bigler P
Drug Metab Dispos; 1980; 8(3):173-7. PubMed ID: 6104582
[TBL] [Abstract][Full Text] [Related]
18. The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
BUTLER TC
J Pharmacol Exp Ther; 1956 Jun; 117(2):160-5. PubMed ID: 13332557
[No Abstract] [Full Text] [Related]
19. Increased systemic availability of drugs during acute ethanol intoxication: studies with mephenytoin in the dog.
Zysset T; Preisig R; Bircher J
J Pharmacol Exp Ther; 1980 Apr; 213(1):173-8. PubMed ID: 7188964
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians.
Jurima M; Inaba T; Kadar D; Kalow W
Br J Clin Pharmacol; 1985 Apr; 19(4):483-7. PubMed ID: 3994895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
